Informations:
Erreur:
ID
12839
Description
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00004814
Lien
https://clinicaltrials.gov/show/NCT00004814
Mots-clés
Versions (1)
- 29/12/2015 29/12/2015 -
Téléchargé le
29 décembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Multiple Sclerosis NCT00004814
Eligibility Multiple Sclerosis NCT00004814
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00004814
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
multiple sclerosis
Item
clinically or laboratory-supported definite multiple sclerosis
boolean
C0026769 (UMLS CUI [1])
neurological status
Item
neurologically stable for at least 30 days prior to entry expanded disability status scale score no greater than 5
boolean
C0746866 (UMLS CUI [1])
C3830336 (UMLS CUI [2])
C3830336 (UMLS CUI [2])
relapses
Item
at least 2 documented relapses within 2 years prior to entry onset of first relapse at least 1 year prior to randomization
boolean
C0277556 (UMLS CUI [1])
biologic therapy
Item
biologic therapy: no prior copolymer 1
boolean
C0005527 (UMLS CUI [1])
immunosuppressive therapy
Item
immunosuppressive therapy: no prior cytotoxic immunosuppressives, i.e.: azathioprine cyclophosphamide cyclosporine at least 30 days since corticosteroids
boolean
C0021079 (UMLS CUI [1])
C0004482 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0004482 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
radiotherapy
Item
radiotherapy: no prior lymphoid irradiation
boolean
C0024230 (UMLS CUI [1])
patient characteristics
Item
not hiv or htlv-i seropositive no insulin-dependent diabetes mellitus no lyme disease no requirement for aspirin or chronic nonsteroidal anti-inflammatory drugs no pregnant or nursing women adequate contraception required of fertile women
boolean
C0019682 (UMLS CUI [1])
C0020094 (UMLS CUI [2])
C0011854 (UMLS CUI [3])
C0024198 (UMLS CUI [4])
C0003211 (UMLS CUI [5])
C0032961 (UMLS CUI [6])
C0006147 (UMLS CUI [7])
C1999124 (UMLS CUI [8])
C0020094 (UMLS CUI [2])
C0011854 (UMLS CUI [3])
C0024198 (UMLS CUI [4])
C0003211 (UMLS CUI [5])
C0032961 (UMLS CUI [6])
C0006147 (UMLS CUI [7])
C1999124 (UMLS CUI [8])